• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL BRASIL LTDA. (NOVA LIMA) SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL BRASIL LTDA. (NOVA LIMA) SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TF-21A
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Aortic Insufficiency (1715); Calcium Deposits/Calcification (1758); Pulmonary Edema (2020); Cusp Tear (2656)
Event Type  Injury  
Event Description
A 21mm trifecta tissue valve was implanted on (b)(6) 2010 to treat the patient's aortic insufficiency.The patient's native aortic valve was severely calcified and excised prior to implant.One week post-implant, a transesophageal echo (tee) showed a peak/mean gradient of 18mm/8mm hg respectively without aortic regurgitation.In 2014, a routine echocardiography confirmed a normal, functioning aortic valve.In (b)(6) 2015, the patient presented with acute pulmonary edema due to severe aortic insufficiency caused by a reported tear in the cusp adjacent to the right coronary.On (b)(6) 2015, a tee was performed due to the potential for endocarditis; the tee revealed a possible tear or prolapse of the anterior cusp.Cultures performed (b)(6) 2015 were negative for bacteria.The valve was explanted (b)(6) and at the time of explant, the annulus was noted to be calcified.A 23mm non-sjm valve was implanted.
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
The results of the investigation concluded circumferential fibrous pannus ingrowth on the inflow surface narrowing the inflow diameter to 14-15 mm, and a tear in cusps 1 and 2.There was no evidence of acute inflammation and special stains were negative for organisms.No evidence was found to suggest the cause of the pannus and tearing was due to an intrinsic defect in the valve, as supported by review of the valve's device history record and the analysis performed.The cause of the reported event resulting in explant remains unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL BRASIL LTDA. (NOVA LIMA)
caixa postal 106
belo horizonte 3400 0-00
BR  34000-000
Manufacturer (Section G)
ST. JUDE MEDICAL BRASIL LTDA. (NOVA LIMA)
caixa postal 106
belo horizonte 3400 0-00
BR   34000-000
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517564470
MDR Report Key4650357
MDR Text Key5600659
Report Number3001743903-2015-00017
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeBE
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/11/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date10/11/2012
Device Model NumberTF-21A
Device Catalogue NumberTF-21A
Device Lot Number3240733
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/08/2015
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/11/2015
Initial Date FDA Received04/01/2015
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received05/01/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/12/2010
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age83 YR
-
-